An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present).
Armstrong D, Hanafi M, Frett B. An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present). Expert Opin Ther Pat. 2025 Aug; 35(8):859-873.